634 related articles for article (PubMed ID: 33035628)
1. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
[TBL] [Abstract][Full Text] [Related]
3. Effect of COVID-19 on patients with compensated chronic liver diseases.
Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection in patients with autoimmune hepatitis.
Marjot T; Buescher G; Sebode M; Barnes E; Barritt AS; Armstrong MJ; Baldelli L; Kennedy J; Mercer C; Ozga AK; Casar C; Schramm C; ; Moon AM; Webb GJ; Lohse AW
J Hepatol; 2021 Jun; 74(6):1335-1343. PubMed ID: 33508378
[TBL] [Abstract][Full Text] [Related]
5. Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care.
Saviano A; Wrensch F; Ghany MG; Baumert TF
Hepatology; 2021 Aug; 74(2):1088-1100. PubMed ID: 33332624
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
Ge J; Pletcher MJ; Lai JC;
Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
[TBL] [Abstract][Full Text] [Related]
7. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.
Shalimar ; Elhence A; Vaishnav M; Kumar R; Pathak P; Soni KD; Aggarwal R; Soneja M; Jorwal P; Kumar A; Khanna P; Singh AK; Biswas A; Nischal N; Dar L; Choudhary A; Rangarajan K; Mohan A; Acharya P; Nayak B; Gunjan D; Saraya A; Mahapatra S; Makharia G; Trikha A; Garg P
Indian J Gastroenterol; 2020 Jun; 39(3):285-291. PubMed ID: 32803716
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.
Satapathy SK; Roth NC; Kvasnovsky C; Hirsch JS; Trindade AJ; Molmenti E; Barish M; Hirschwerk D; Da BL; Bernstein D;
Hepatol Int; 2021 Jun; 15(3):766-779. PubMed ID: 33826042
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.
Brozat JF; Hanses F; Haelberger M; Stecher M; Dreher M; Tometten L; Ruethrich MM; Vehreschild JJ; Trautwein C; Borgmann S; Vehreschild MJGT; Jakob CEM; Stallmach A; Wille K; Hellwig K; Isberner N; Reuken PA; Geisler F; Nattermann J; Bruns T;
United European Gastroenterol J; 2022 May; 10(4):409-424. PubMed ID: 35482663
[TBL] [Abstract][Full Text] [Related]
10. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
11. High rates of 30-day mortality in patients with cirrhosis and COVID-19.
Iavarone M; D'Ambrosio R; Soria A; Triolo M; Pugliese N; Del Poggio P; Perricone G; Massironi S; Spinetti A; Buscarini E; Viganò M; Carriero C; Fagiuoli S; Aghemo A; Belli LS; Lucà M; Pedaci M; Rimondi A; Rumi MG; Invernizzi P; Bonfanti P; Lampertico P
J Hepatol; 2020 Nov; 73(5):1063-1071. PubMed ID: 32526252
[TBL] [Abstract][Full Text] [Related]
12. Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma.
Pazgan-Simon M; Kucharska M; Górka-Dynysiewicz J; Simon K
Pharmacol Rep; 2022 Dec; 74(6):1306-1314. PubMed ID: 36394820
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.
Mendizabal M; Ridruejo E; Piñero F; Anders M; Padilla M; Toro LG; Torre A; Montes P; Urzúa A; Gonzalez Ballerga E; Silveyra MD; Michelato D; Díaz J; Peralta M; Pages J; García SR; Gutierrez Lozano I; Macias Y; Cocozzella D; Chavez-Tapia N; Tagle M; Dominguez A; Varón A; Vera Pozo E; Higuera-de la Tijera F; Bustios C; Conte D; Escajadillo N; Gómez AJ; Tenorio L; Castillo Barradas M; Schinoni MI; Bessone F; Contreras F; Nazal L; Sanchez A; García M; Brutti J; Cabrera MC; Miranda-Zazueta G; Rojas G; Cattaneo M; Castro-Narro G; Rubinstein F; Silva MO
Ann Hepatol; 2021; 25():100350. PubMed ID: 33864948
[TBL] [Abstract][Full Text] [Related]
14. Chronic Liver Disease and Cirrhosis are Associated with Worse Outcomes Following SARS-CoV-2 Infection.
Wong RJ; Zhang Y; Thamer M
J Clin Exp Hepatol; 2023; 13(4):592-600. PubMed ID: 36777086
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
[TBL] [Abstract][Full Text] [Related]
16. Cirrhosis and Severe Acute Respiratory Syndrome Coronavirus 2 Infection in US Veterans: Risk of Infection, Hospitalization, Ventilation, and Mortality.
Ioannou GN; Liang PS; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Fan VS; Dominitz JA
Hepatology; 2021 Jul; 74(1):322-335. PubMed ID: 33219546
[TBL] [Abstract][Full Text] [Related]
17. Breakthrough SARS-CoV-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: A National COVID Cohort Collaborative study.
Ge J; Digitale JC; Pletcher MJ; Lai JC;
Hepatology; 2023 Mar; 77(3):834-850. PubMed ID: 36799617
[TBL] [Abstract][Full Text] [Related]
18. Increased Hepatic Expression of SARS-CoV-2 Entry Points and Proinflammatory Cytokines in Cirrhosis.
Limon-De La Rosa N; Cervantes-Alvarez E; Navarro-Alvarez N
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):239-241.e3. PubMed ID: 34481957
[TBL] [Abstract][Full Text] [Related]
19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
20. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study.
Afify S; Eysa B; Hamid FA; Abo-Elazm OM; Edris MA; Maher R; Abdelhalim A; Abdel Ghaffar MM; Omran DA; Shousha HI
World J Gastroenterol; 2021 Nov; 27(42):7362-7375. PubMed ID: 34876795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
